| Dr Jaldeep H Daulat, DO | |
|
3975 S Durango Dr Ste 107, Las Vegas, NV 89147-4156 | |
| (702) 628-5333 | |
| (702) 974-0440 |
| Full Name | Dr Jaldeep H Daulat |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 41 Years |
| Location | 3975 S Durango Dr Ste 107, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114949492 | NPI | - | NPPES |
| 070003254 | Other | NV | RAILROAD MEDICARE |
| 1114949492 | Medicaid | NV | |
| 070012029 | Other | AZ | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 363 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| J H Daulat Do Pc | 0143502328 | 3 |
| Thomas Dermatology | 9830277136 | 26 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
› Verified 3 days ago
| Entity Name | J Robert West Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295338416 PECOS PAC ID: 8729990973 Enrollment ID: O20040527000772 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
› Verified 3 days ago
| Entity Name | Jaldeep H Daulat Do Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366544124 PECOS PAC ID: 6406830751 Enrollment ID: O20040713000299 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
› Verified 3 days ago
| Entity Name | Leavitt Medical Associates Of Nevada Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124436480 PECOS PAC ID: 0648492181 Enrollment ID: O20141117001171 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
› Verified 3 days ago
| Entity Name | J H Daulat Do Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194268987 PECOS PAC ID: 0143502328 Enrollment ID: O20170124000506 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jaldeep H Daulat, DO 9750 W Skye Canyon Park Dr, Suite 160 Box 103, Las Vegas, NV 89166 Ph: (702) 683-1727 | Dr Jaldeep H Daulat, DO 3975 S Durango Dr Ste 107, Las Vegas, NV 89147-4156 Ph: (702) 628-5333 |
News Archive
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
As a world leader in oral biology and salivary diagnostics, the Forsyth Institute is working with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative as an advisor and critical resource in the effort to develop and eventually deploy millions of accurate, rapid COVID-19 point-of-care tests used daily in schools, colleges, universities, and for testing underserved populations.
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient's risk of having a heart attack.
Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.
› Verified 3 days ago
Mrs. Miriam S Bettencourt, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6170 N Durango Dr Ste 140, Las Vegas, NV 89149 Phone: 702-430-5333 | |
Dr. Lionel Julian Handler, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10105 Banburry Cross Dr, Suite 350, Las Vegas, NV 89144 Phone: 702-243-6400 Fax: 702-243-4913 | |
Dr. Alison Yah-san Tam, D.O. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8530 W. Sunset Rd #130, Las Vegas, NV 89113 Phone: 702-822-2100 Fax: 702-822-2105 | |
Dr. Dominick J Addonizio I, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 653 N Town Center Dr, Las Vegas, NV 89144 Phone: 702-450-7546 Fax: 702-869-6146 | |
Dr. James Del Rosso, DO Dermatology Medicare: Medicare Enrolled Practice Location: 9097 W Post Rd Ste 100, Las Vegas, NV 89148 Phone: 702-430-5333 Fax: 702-430-5335 | |
Elizabeth Ann Langford, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6460 Medical Center St Ste 350, Las Vegas, NV 89148 Phone: 702-255-6647 Fax: 702-933-1444 |